19.8 C
New York
Thursday, August 5, 2021

Correcting Altered Brain Circuit Could Tackle Coinciding Obesity and Depression | Nutrition Fit


Summary: Mice that consumed high-fat diets not only became obese, they also displayed an increased risk of depression and anxiety symptoms. This was mediated by a defective brain circuit. When the disruptions were corrected either genetically or pharmaceutically, mice displayed fewer symptoms of depression and experienced weight loss.

Source: Baylor College of Medicine

Research has found that obesity and mental disorders such as depression and anxiety seem to often go hand in hand. Researchers at Baylor College of Medicine and collaborating institutions are providing new insights into this association by identifying and characterizing a novel neural circuit that mediates the reciprocal control of feeding and psychological states in mouse models.

Similar to human patients, mice that consumed a high-fat diet not only became obese, but also anxious and depressed, a condition mediated by a defective brain circuit. When the researchers genetically or pharmacologically corrected specific disruptions they had observed within this circuit, the mice became less anxious and depressed and later lost excess body weight.

Interestingly, weight loss was not the result of lack of appetite, but of the animals’ change of food preference. Before the treatment, the mice naturally preferred to eat a high-fat diet, but after the treatment they turned their preference toward a healthier diet with reduced fat and abundant protein and carbohydrates.

The findings, published in the journal Molecular Psychiatry, for the first time, not only reveal a key regulatory mechanism for coinciding obesity and mental disorders, but also suggest the possibility of a pharmacological treatment.

“Reports indicate that 43% of adults with depression are obese and that adults with mental illness are more likely to develop obesity than those who are mentally healthy,” said corresponding author Dr. Qi Wu, a Pew Scholar for Biomedical Sciences, Kavli Scholar and assistant professor in pediatrics-nutrition at Baylor’s Children’s Nutrition Research Center.

See also  Happiness Can Be Learned - Neuroscience News | Nutrition Fit

“Factors such as hormonal dysregulation, genetic deficiency and inflammation have been proposed to be involved in the connection between obesity and mental disorders. Here we provide evidence that supports the involvement of a neural component.”

See also  Happiness Can Be Learned - Neuroscience News | Nutrition Fit

To investigate the neuronal circuits that could be involved in reciprocally regulating weight gain and depression or anxiety, the researchers provided mice with a high-fat diet. As expected, the animals became obese. They also developed anxiety and depression. In these mice, the team studied the function of neuronal circuits.

“We discovered in normal mice that two groups of brain cells, dBNST and AgRP neurons located in separate brain areas, form a circuit or connection to each other by extending cellular projections,” said co-first author Dr. Guobin Xia, postdoctoral associate in the Wu lab. “This newly discovered circuit was malfunctioning in mice that were both obese and depressed.”

“Using genetic approaches, we identified specific genes and other mediators that were altered and mediated the circuit’s malfunction in the obese and depressed mice,” said co-first author Dr. Yong Han, postdoctoral associate in the Wu lab.

This shows a model of a head and a brain
Similar to human patients, mice that consumed a high-fat diet not only became obese, but also anxious and depressed, a condition mediated by a defective brain circuit. Image is in the public domain

“Importantly, genetically restoring the neural defects to normal eliminated the high fat diet-induced anxiety and depression and also reduced body weight,” Xia said. “We were surprised to see that the animals lost weight, not because they lost their appetite, but because genetically-aided readjustment of the mental states changed their feeding preference from high-fat to low-fat food.”

“Keeping in mind translational applications of our findings to the clinic, we investigated the possibility of restoring the novel circuit pharmacologically,” Wu said.

See also  A New Cell Type Implicated in Chronic Pain and Inflammation | Nutrition Fit

“We discovered that the combination of two clinically-approved drugs, zonisamide and granisetron, profoundly reduced anxiety and depression in mice and promoted weight loss by synergistically acting upon two different molecular targets within our newly identified brain circuit. We consider that our results provide convincing support for further studies and future clinical trials testing the value of a cocktail therapy combining zonisamide and granisetron (or a selection of their derivatives) to treat metabolic-psychiatric diseases.”

See also  'Walking' Molecule Superstructures Could Help Create Neurons for Regenerative Medicine | Nutrition Fit

Other contributors to this work include Fantao Meng, Yanlin He, Dollada Srisai, Monica Farias, Minghao Dang, Richard D. Palmiter and Yong Xu. The authors are affiliated with one of the following institutions: Baylor College of Medicine, Vanderbilt University School of Medicine, University of Texas MD Anderson Cancer Center and University of Washington, Seattle.

Funding: This work was supported by NIH grants (1R01DK109194, 1R56DK109194, R01DK093587, R01DK101379, R01DK117281, and R01-DA24908), Pew Charitable Trust awards, American Diabetes Association awards (7-694 13-JF-61, 1-17-700 PDF-138), American Heart Association awards (17GRNT32960003), USDA/CRIS grants (3092-5-001-059), Baylor Collaborative Faculty Research Investment Program grants and Faculty Start-up grants from USDA/ARS.

Further support was provided in part by NIH Centers of Biomedical Research Excellence, COBRE grant (P20 GM135002), IDDRC Grant Number U54HD083092 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the Clinical and Translational Proteomics Service Center at the University of Texas Health Science and the Howard Hughes Medical Institute.

About this obesity and depression research news

Source: Baylor College of Medicine
Contact: Homa Shalchi – Baylor College of Medicine
Image: The image is in the public domain

Original Research: Open access.
Reciprocal control of obesity and anxiety–depressive disorder via a GABA and serotonin neural circuit” by Guobin Xia, Yong Han, Fantao Meng, Yanlin He, Dollada Srisai, Monica Farias, Minghao Dang, Richard D. Palmiter, Yong Xu & Qi Wu. Molecular Psychiatry


Abstract

See also  'Walking' Molecule Superstructures Could Help Create Neurons for Regenerative Medicine | Nutrition Fit

See also

This shows a cartoon of people in their houses

Reciprocal control of obesity and anxiety–depressive disorder via a GABA and serotonin neural circuit

The high comorbidity between obesity and mental disorders, such as depression and anxiety, often exacerbates metabolic and neurological symptoms significantly. However, neural mechanisms that underlie reciprocal control of feeding and mental states are largely elusive.

Here we report that melanocortin 4 receptor (MC4R) neurons located in the dorsal bed nucleus of the stria terminus (dBNST) engage in the regulation of mentally associated weight gain by receiving GABAergic projections from hypothalamic AgRP neurons onto α5-containing GABAA receptors and serotonergic afferents onto 5-HT3 receptors.

Chronic treatment with a high-fat diet (HFD) significantly blunts the hyperexcitability of AgRP neurons in response to not only hunger but also anxiety and depression-like stimuli. Such HFD-mediated desensitization reduces GABAergic outputs from AgRP neurons to downstream MC4RdBNST neurons, resulting in severe mental dysregulation. Genetic enhancement of the GABAAR-α5 or suppression of the 5-HT3R within the MC4RdBNST neurons not only abolishes HFD-induced anxiety and depression but also robustly reduces body weight by suppression of food intake.

See also  ‘Magic’ CogniShield Reviews- Warning – Read Shocking Side Effects First!

To gain further translational insights, we revealed that combined treatment of zonisamide (enhancing the GABAAR-α5 signaling) and granisetron (a selective 5-HT3R antagonist) alleviates mental dysfunction and yields a robust reversal of diet-induced obesity by reducing total calorie intake and altering food preference towards a healthy low-fat diet.

Our results unveil a neural mechanism for reciprocal control of appetite and mental states, which culminates in a novel zonisamide-granisetron cocktail therapy for potential tackling the psychosis-obesity comorbidity.



Source link

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

22,036FansLike
2,887FollowersFollow
SubscribersSubscribe
- Advertisement -spot_img

Latest Articles

Read previous post:
Quality Sleep Extremely Elusive for Most During Pandemic: Survey | Nutrition Fit

Fewer than 1 in 10 people report they are getting "very good sleep" at night — just one of several eye-opening...

Close